Pembet Singana, Brice
Casimiro, Prisca Nadine
Matondo Diassivi, Brunelle
Kobawila, Simon Charles
Youndouka, Jean-Mermoz
Basco, Leonardo K. http://orcid.org/0000-0002-8812-8185
Ringwald, Pascal
Briolant, Sébastien
Ndounga, Mathieu
Clinical trials referenced in this document:
Documents that mention this clinical trial
Prevalence of malaria among febrile patients and assessment of efficacy of artemether-lumefantrine and artesunate-amodiaquine for uncomplicated malaria in Dolisie, Republic of the Congo
https://doi.org/10.1186/s12936-022-04143-4
Funding for this research was provided by:
Bill and Melinda Gates Foundation (OPP1140599)
Article History
Received: 21 October 2021
Accepted: 28 March 2022
First Online: 2 May 2022
Declarations
:
: The present study was reviewed and approved by the institutional ethics committee of research in health science (Comité d’Ethique de la Recherche en Sciences de la Santé, [CERSSA]) of the Congolese Ministry of Research and Ministry of Health and Population and the Ethical Review Committee of the WHO. Before enrolment of children in the cohort, their parents were informed about the objectives of the study, benefits, and constraints associated with participation in the study in French or in one of the two national languages (Lingala or Kituba). Parents or legal guardians who agreed to participate in the study signed the informed consent form.
: Not applicable.
: All authors declare that they have no competing interests.